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Abstract
GAGE proteins are highly similar, primate-specific molecules with unique primary structure and undefined cellular roles.
They are restricted to cells of the germ line in adult healthy individuals, but are broadly expressed in a wide range of
cancers. In a yeast two-hybrid screen we identified the metazoan transcriptional regulator, Germ cell-less (GCL), as an
interaction partner of GAGE12I. GCL directly binds LEM-domain proteins (LAP2b, emerin, MAN1) at the nuclear envelope,
and we found that GAGE proteins were recruited to the nuclear envelope inner membrane by GCL. Based on yeast two-
hybrid analysis and pull-down experiments of GCL polypeptides, GCL residues 209–320 (which includes the BACK domain)
were deduced sufficient for association with GAGE proteins. GAGE mRNAs and GCL mRNA were demonstrated in human
testis and most types of cancers, and at the protein level GAGE members and GCL were co-expressed in cancer cell lines.
Structural studies of GAGE proteins revealed no distinct secondary or tertiary structure, suggesting they are intrinsically
disordered. Interestingly GAGE proteins formed stable complexes with dsDNA in vitro at physiological concentrations, and
GAGE12I bound several different dsDNA fragments, suggesting sequence-nonspecific binding. Dual association of GAGE
family members with GCL at the nuclear envelope inner membrane in cells, and with dsDNA in vitro, implicate GAGE
proteins in chromatin regulation in germ cells and cancer cells.
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Introduction
The GAGE family of highly identical, small oligomeric proteins
is expressed from a locus containing 13–39 copies of nearly
identical genes on the X-chromosome [1,2]. GAGE genes are only
present in higher primates and have undergone rapid expansion
possibly due to strong positive selection [3]. In healthy individuals
GAGE expression is limited to germ cells [4], but transcription of
GAGE genes is activated upon epigenetic dysregulation in cancer
cells [5]. GAGE proteins are expressed in a wide range of cancers,
and their expression correlates with poor prognosis in stomach
cancer, esophageal carcinoma and neuroblastoma, indicating a
role in tumorigenesis [6]. GAGE proteins are known to increase
cellular resistance to various cytotoxic agents by directly associ-
ating with, and affecting the level of, apoptotic regulators IRF1
and NPM1 [7,8], but little is known about their molecular or
cellular functions.
Here we report that GAGE proteins interact with GCL, a
metazoan protein important for nuclear envelope integrity and
germ cell development in Drosophila and mice [9,10]. In both
species, GCL localizes at the inner nuclear membrane, and several
lines of evidence suggest that GCL inhibits transcription: GCL is
required to silence transcription in Drosophila germ cells [11], and
in mammalian cells, GCL binds the heterodimeric transcription
factor DP and thereby inhibits DP-E2F-dependent genes, which
are required for entry into S-phase. GCL also directly binds at
least three LEM-domain proteins (emerin, MAN1 and LAP2b
[12–14]) located at the nuclear inner membrane, and appears to
require LEM-domain proteins as co-repressors in vivo [13,15].
LEM-domain proteins bind lamins (nuclear intermediate fila-
ments) and are key components of nuclear ‘lamina’ structure.
The nuclear ‘lamina’ component of the nucleoskeleton consists
of networks of nuclear intermediate filaments formed by A-type or
B-type lamins [16] in conjunction with barrier-to-autointegration
factor (BAF) [17,18] and LEM-domain proteins such as emerin
[19,20]. Lamins interact with chromatin and a variety of
structural, regulatory and signaling proteins in the nucleus [21],
and influence nuclear structure and many pathways including
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development, differentiation, cell proliferation and apoptosis
[22,23]. Changes in the composition or integrity of the
nucleoskeleton might contribute, by mechanisms that remain
poorly understood, to malignant transformation or tumor
progression [24]. For example the A/T-rich-DNA-binding protein
SATB1 normally forms a specialized chromatin-silencing nucleos-
keletal structure only in thymocytes; breast cancer cells with high
SATB1 expression show grossly misregulated gene expression
[25,26]. Cells that overexpress GCL have defective nuclear
structure, implicating GCL as a structural component of the
nucleus [9,10].
We report GAGE proteins are recruited to the nuclear lamina
via GCL in cells, and bind dsDNA in vitro. These results suggest
that GAGE proteins might contribute to tumorigenesis by a
mechanism that involves GCL and chromatin, and potentially also
nuclear lamina organization.
Results
GAGE Proteins Interact with the Transcriptional Regulator
Germ Cell-less (GCL)
To better understand the cellular functions of GAGE proteins,
we used a yeast two-hybrid screen to identify potential partners.
TetR-based screening of a testis cDNA library using full length
GAGE12I as bait yielded one clone (D2) exhibiting growth on
Ura- medium and blue coloration on X-Gal medium, indicating
interaction between bait and prey (Fig. 1A). The prey plasmid of
D2 contained an open reading frame encoding residues 84–320 of
human germ cell-less homolog 1 (GCL, alias GMCL1;
NM178439.3). GCL association with GAGE12I was indepen-
dently verified by Luciferase-based (Luminescence-based mam-
malian interactome mapping; ‘Lumier’; [27]) pull-down assays.
Luciferase-tagged GCL and Protein A-tagged GAGE12I (or
reciprocal contructs) were transiently expressed in HEK293 cells.
We then isolated protein A fusions using IgG-coated beads and
measured luciferase activity (Fig. 1B). Normalized luciferase signals
(bound/input) were converted to Z scores, representing the
number of standard deviations from the mean of a large set of
independently derived, non-interacting Lumier protein pairs [27].
GAGE12I-GCL pairs exhibited Z scores in the range of 3.4–5.3
(Fig. 1B), clearly indicating an interaction between these proteins.
In this assay GCL also associated with GAGE2B (Z scores: 1.8–
5.3; Fig. 1B), which represents the GAGE2-type (GAGE2A-E)
family, all of which lack a tyrosine at position 11 that can be
phosphorylated in other GAGE proteins [28]. This suggested
GCL associates directly or indirectly with all characterized
members of the GAGE family. Since the yeast two-hybrid analysis
and pull-down assays are both complex systems, we also tested
potential direct binding between GAGE proteins and GCL using
recombinant His-tagged GAGE12I produced in yeast and a
commercially-available bacterially-expressed GCL-GST fusion
protein (Fig. 1C). However, direct binding of GAGE12I and
GCL was not detected under these conditions. We speculate that
direct binding of GAGE and GCL might: (a) require a cofactor or
posttranslational modification not provided during bacterial
expression; (b) be sterically hindered by the His-tag on GAGE12I
or the GST-tag on GCL. Alternatively GAGE and GCL might
associate indirectly.
Our two-hybrid screen specifically recovered GCL residues 84–
320, which includes predicted BTB/POZ and BACK domains
(residues 109–200 and 214–282, respectively). In other proteins,
BTB/POZ domains are implicated in binding to DNA or actin
[29,30], whereas BACK-domains are mainly alpha-helical but
have no generally-ascribed function [31]. To determine which
GCL domains were sufficient for GAGE12I association, we
repeated the Lumier assay with Protein A-tagged GAGE12I and
the Luciferase-tagged GCL fragments shown in Figure 2. From
these experiments, we deduced GCL residues 209–320 were both
required and sufficient to associate with GAGE12I in cells. This
region included the BACK domain (residues 214–282) plus 38
adjacent residues (residues 283–320). Our Jpred 3 (University of
Dundee, Scotland, UK) analysis predicted that GCL residues 209–
320 have several helical motifs and random coil segments (Fig. S1).
Notably GCL residues 232–285 are essential to bind the DP
subunit of the heterodimeric transcription factor E2F-DP [29].
This is interesting because E2F-DP-dependent genes promote
proliferation (entry into S-phase) and are major targets of
repression by the tumor suppressor retinoblastoma (pRb), which
binds the E2F subunit [32–34]. GCL residues 232–285, which are
essential to bind DP, are included within the deduced GAGE-
association region (GCL residues 209–320) (Fig. 2 and Fig. S1).
This overlap suggested at least two scenarios. First, GAGE and DP
might compete for binding to GCL, and second, GAGE proteins
might influence E2F-DP-dependent gene expression.
GAGE and GCL are Co-expressed in Testis and Cancers
GAGE family members are expressed detectably only in
germline cells and briefly in specific cell types during primate
fetal development (i.e. cells of the early ectoderm, stromal cells of
the sex cord and fetal adrenal cortex cells), as determined by
immunohistochemical [4,35] and RT-PCR analysis (Fig. 3A) using
antibodies and PCR primers expected to recognize all known
members of the GAGE family. However, GAGE proteins are
expressed in 10–40% of wide range of human cancers [4]. GCL
mRNA is detected ubiquitously in Drosophila and mouse cells
[10,36–38], but its expression in normal and malignant human
cells had not been systematically examined. To determine which
human tissues might express both GAGE and GCL, we used
quantitative RT-PCR to measure GAGE and GCL mRNA levels
in 48 different tissues (Fig. 3A and 3B, respectively). GAGE
mRNA was detected at low levels in epididymous and spleen, with
high levels in testis (Fig. 3A), as expected. Consistent with mouse
and Drosophila, GCL mRNA was detected in all but one normal
human tissue tested; the highest levels were detected in pituitary,
and the exception was muscle, where GCL mRNA was not
detected (Fig. 3B). Since GCL is specifically expressed and
required in Drosophila and mouse germ cells, we speculate that
GCL expression in human testis is also likely localized to germ
cells, where GAGE proteins are abundant [4]. GCL mRNA was
also detected in all types of cancer examined, including breast,
liver, lung and thyroid cancer which were previously shown to also
express GAGE proteins [4], and there was no clear tendency
toward up- or down-regulation of GCL mRNA expression in any
particular cancer type (Fig. 3C). We next investigated the
expression of GCL and GAGE proteins in a panel of human
cancer cells lines of various origins using Western blotting (Fig. 4).
GCL was detected in 8 out of 9 cell lines, including melanomas,
breast cancers, lung cancer and embryonic carcinoma, and was
co-expressed with GAGE proteins in 6 of these 8 cell lines.
Potential co-localization of GCL and GAGE proteins in sections
of normal human tissues and cancers could not be examined due
to the lack of suitable GCL antibodies. Since GCL mRNA is
nearly ubiquitous in human tissues, one might expect the same for
GCL protein. However this cannot be assumed, since GCL
mRNA is repressed at the translational level in embryos as a
mechanism to limit the expression of GCL protein to the germline
[39]. Supporting the hypothesis that GCL protein expression is
restricted, GCL-null mice phenotypes were detected in only three
GAGE Proteins Bind GCL
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cell types (liver, pancreas and testis) [10]. Although GCL protein
expression may be restricted in normal human tissues our analysis
of human cancer cell lines suggest that GCL protein is expressed in
several types of cancer.
These results were consistent with potential association of
human GAGE and GCL in male germ cells and different types of
cancer cells.
Figure 1. GAGE proteins interact with GCL. A. GAGE12I was used as bait in a yeast two-hybrid screen of a testis cDNA library. Plasmids encoding
putative preys identified in the primary screen were rescued and retransformed into EGY42 with the bait GAGE12I vector (B) or control vector (C).
Clone D2 exhibited growth on Ura- medium and blue coloration on X-Gal medium, indicating an interaction between bait and prey. The encoded
prey polypeptide of D2 comprised human GCL residues 84–320, which includes the proposed BTB/POZ and BACK domains. B. Interaction between
GCL and GAGE12I was verified by Lumier pull-downs from HEK293 cells co-transfected with Protein A-fused GAGE and Luciferase-fused GCL.
Normalized luciferase signals (bound/input) are presented as Z scores, representing the number of standard deviations from the mean of a large set
of independently derived, non-interacting Lumier protein pairs (see Materials and Methods for details). C. Pull-down assay with recombinant His-
tagged GAGE12I and GST-GCL.
doi:10.1371/journal.pone.0045819.g001
Figure 2. Identification of the GAGE-binding region of GCL. The binding of different GCL deletion mutants to GAGE12I was tested by Lumier
assay (as in Fig. 1). The region deduced as essential for GAGE binding (GCL residues 209–320) includes residues 232–285, which are sufficient to bind
transcriptional activator DP (*) [29].
doi:10.1371/journal.pone.0045819.g002
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Figure 3. mRNA expression of GAGE and GCL genes overlaps in testis and cancers. A-C. Quantitative RT-PCR analysis of the relative
expression of mRNAs encoding all known members of the GAGE family (A) or GCL (B) in normal tissues, reveals co-expression in testis. GCL mRNA was
also widely expressed in different types of human cancer (C), including breast, liver, lung and thyroid cancer which were previously shown to also
express GAGE proteins [4].
doi:10.1371/journal.pone.0045819.g003
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GCL Recruits GAGE Proteins to the Inner Nuclear
Envelope
GCL localizes diffusely within the nucleus and also near the
nuclear envelope in Drosophila [38] and mouse cells [13], consistent
with its direct binding in vitro to nuclear membrane proteins LAP2b,
emerin and MAN1 [12–14]. To determine if GCL influenced the
localization of GAGE proteins, we overexpressedMyc-tagged GCL
in HeLa cells and used indirect immunofluorescence staining to
verify both the nuclear localization of GCL-Myc and its co-
localization with endogenous A-type lamins near the nuclear
envelope (Fig. 5A). When overexpressed by itself in HeLa cells,
GAGE12I localized diffusely with the brightest signals inside the
nucleus (Fig. 5B), consistent with the localization of endogenous
GAGE in many other cell lines and tissues [4]. Also as expected,
overexpressed GCL-Myc localized both at the nuclear envelope
(Fig. 5C) and diffusely in the nucleoplasm [10,13]. Interestingly, in
HeLa cells that transiently expressed both GAGE and GCL-Myc,
most GAGE proteins co-localized near the nuclear envelope with
GCL-Myc, as shown for GAGE12I (Fig. 5D) and GAGE1 (Fig. 5E).
The same results were obtained in transfected HCT116 cells (data
not shown). Similarly in two melanoma cell lines (MZ2-MEL and
SK-MEL-31), transient expression of GCL-Myc shifted the
distribution of endogenous GAGE proteins toward the nuclear
envelope (Fig. 5F,G). We concluded exogenous GCL can recruit
exogenous and endogenousGAGEproteins to the nuclear envelope.
Although association between endogenous GCL and GAGE
proteins in human cells and tissues could not be investigated due to
the lack of GCL antibodies suitable for immunocyto- and
immunohistochemistry, GAGE proteins might have been expected
to localize at the nuclear membrane in cancer cells lines
demonstrated to express endogenous GCL by Western blotting
(e.g. HeLa, HCT116, MZ2-MEL; Fig. 4). However, in these cells
GAGE proteins were observed throughout the nuclear compart-
ment. This could be due to a need for high cellular levels of GCL,
only achievable by overexpression, to recruit enough of the
nuclear GAGE proteins to expose its localization at the nuclear
membrane. Thus, GAGE proteins may localize to both the
nuclear membrane and nucleoplasm in cells with normal GCL
levels. Notably, immunohistochemical staining of human clinical
specimens with GAGE antibodies revealed non-diffuse, dense
GAGE signals that appeared to concentrate near the nuclear
periphery in fetal adrenal cortex cells (Fig. 5H), primordial germ
cells of the mesonephros (Fig. 5I), malignant melanoma cells
(Fig. 5J) and breast carcinoma cells (Fig. 5K), further substanti-
ating that GAGE proteins associate with the inner membrane of
the nuclear envelope.
GAGE Proteins are Intrinsically Disordered
Previous analysis of native and recombinant GAGE proteins by
SDS-PAGE and size exclusion chromatography demonstrated an
apparent mass of 26 kDa, which was larger than its predicted and
MALDI MS-confirmed mass of ,13 kDa [2,4]. This anomalous
migration might reflect the unusual amino acid composition of
GAGE proteins, which have few hydrophobic residues (15 of 117)
and many charged residues (36 of 117). However these features are
also characteristic of intrinsically disordered proteins (IDPs)
[40,41]. To consider this possibility we applied two different
algorithms for protein structure prediction, FoldIndex and
metaPrDOS, to GAGE12I, a representative member of the
GAGE family. Both algorithms predicted a high probability of
disorder throughout the protein (Fig. 6A; left and right panels,
respectively). Since GAGE12I is .98% identical to nearly all
other known members of the GAGE family [6], this suggested that
GAGE proteins generally lack secondary structure. The one
exception was GAGE1; our structural prediction for GAGE1,
which has a unique C-terminal domain [6], suggested this C-
terminal region is alpha-helical (Fig. S1).
The potential disorder of GAGE12I was tested by circular
dichroism (CD) and 1H Nuclear Magnetic Resonance (NMR)
spectroscopy. A Far-UV CD spectrum recorded for GAGE-12I
showed only one minimum at around 200 nm (Fig. 6B). This
minimum, and the lack of any distinct negative ellipticity in the
region from 210 to 225 nm (Fig. 6B), showed that GAGE-12I has no
extended type of secondary structure. Confirming this observation,
the 1D 1H-NMR spectrum revealed a narrow dispersion of signals
(Fig. 6C). In the region of the spectrum showing signals from
aliphatic sidechains, we observed no negative chemical shifts. The
narrow dispersion was again clearly seen for amide proton signals in
the region from approximately 7–9 ppm.We concluded GAGE12I
has no distinct secondary or tertiary structure.
GAGE Proteins Bind dsDNA at Physiological
Concentrations
GAGE proteins localize in the nucleus of both normal cells (i.e.
germ cells and fetal adrenal cortex cells) and cancer cells [4]. We
therefore hypothesized GAGE proteins might associate with DNA.
This hypothesis was supported by pull-down experiments showing
that recombinant GAGE12I (expressed in yeast and highly
purified) [2]), and endogenous GAGE proteins present in MZ2-
MEL melanoma cell lysate, bound to native calf thymus DNA
(Fig. 7, A and B respectively).
Figure 4. GCL and GAGE proteins are co-expressed in human
cancer cells lines. GCL and GAGE protein expression was examined in
9 human cancer cells lines derived from cervix (HeLa), colon (HCT116),
melanoma (MZ2-MEL), breast (BrCa-MZ01, SK-BR3, T47D, M4A4, MCF7)
and embryonic cancer (NTERA2) using Western blotting. A375
melanoma cells with exogenous expression of GCL were included as
positive control. Antibodies: GCL pAb1, Sigma Aldrich; GCL pAb2, clone
A14, Santa Cruz Biotech; GAGE mAb, clone M3 [4], beta-actin mAb,
Ab6276; Abcam.
doi:10.1371/journal.pone.0045819.g004
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Electrophoretic mobility shift assays were used to further
analyze the direct association between GAGE proteins and
dsDNA using different restriction fragments from plasmid
pUC10 or pUC19 (Fig. 7C and Fig. S2). At a concentration of
,10 ng/ml (730 nM), GAGE12I caused a subset of dsDNA
molecules to migrate slowly (Fig. 7C). In the presence of 100 ng/ml
GAGE12I (7.3 mM) over 50% of dsDNA migrated slowly
(nucleoprotein ‘complex 1’) and we also detected an even
slower-migrating complex (Fig. 7C, ‘complex 2’), suggesting
potential oligomerization. GAGE12I bound several sequence-
unrelated dsDNA fragments, suggesting DNA sequence-indepen-
dent binding (data not shown). Both complexes were stable in
Figure 5. GAGE proteins are recruited to the nuclear envelope by GCL. A. Immunohistochemical double-staining of Myc-tagged human GCL
and endogenous A-type lamins (lamins A/C) in transfected HeLa cells; GCL co-localized with lamins A/C at the nuclear envelope. B-E. HeLa cells were
transiently transfected with GAGE12I (B), GCL-Myc (C), or GCL-Myc plus either GAGE12I (D) or GAGE1 (E). GCL localized at the nuclear envelope and
recruited GAGE proteins from the nucleoplasm. F-G. Melanoma cell lines MZ2-MEL (F) and SK-MEL-31 (G), which express high levels of endogenous
GAGE, were transfected to express GCL-Myc; immunostaining revealed GCL-mediated translocation of GAGE from the nucleoplasm to the nuclear
envelope. H–K. Immunohistochemical analysis of endogenous GAGE proteins in human normal tissues and tumors revealed a dense GAGE signals
near the nuclear envelope in cells of the fetal adrenal cortex (H), migrating primordial germ cells (I), breast carcinoma cells (J) and malignant
melanoma cell (K) specimens. (GAGE=DAB/brown; Nuclei =Mayers hematoxylin/blue). Bars, 5 mm (A) and 10 mm (B-K).
doi:10.1371/journal.pone.0045819.g005
Figure 6. GAGE proteins are intrinsically disordered. A. Secondary structure and disorder of GAGE-12I predicted by two algorithms: FoldIndex
(left panel) and metaPrDOS (right panel). B. Far-UV CD spectrum of GAGE-12I recorded from 195–250 nm of 4.5 mM GAGE-12I in 100 mM NaCl and
50 mM sodium phosphate, pH 5.5 at 25uC. The minimum at around 200 nm, plus the lack of other distinct minima, clearly indicate the protein is
predominantly unfolded. C. 1D 1H-NMR spectrum of 4 mg/ml GAGE-12I in 100 mM NaCl, 50 mM sodium phosphate pH 5.5, 0.15 mM DSS and 10%
D2O. The very low dispersion of the NMR signals, especially noticeable in the aliphatic region, provides a clear fingerprint of an unfolded protein.
doi:10.1371/journal.pone.0045819.g006
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Figure 7. GAGE proteins bind dsDNA. A–B. Western blot of pulldown experiments testing the binding of recombinant GAGE12I (A) or
endogenous GAGE proteins from MZ2-MEL lysates (B) to cellulose alone, or cellulose-immobilized native calf thymus dsDNA. C. Electrophoretic
mobility shift assays. Each indicated concentration of purified GAGE12I was incubated with the 32P-labelled 90-bp EcoRI-PvuII DNA fragment from
pUC19 at 1 pg/ml; samples were then resolved by agarose gel electrophoresis. D. Same experiment as in (C), but with addition of NaCl. E. Prediction of
putative DNA binding amino acids in GAGE12I using the program BindN. +/2=binding/no binding; 0–9= confidence of binding prediction.
doi:10.1371/journal.pone.0045819.g007
Figure 8. Estimated concentration of GAGE proteins in melanoma cells. A. Dot blots to estimate GAGE protein content in MZ2-MEL and SK-
MEL-31 whole cell lysates by comparison to recombinant GAGE12I. Blots were probed with antibodies expected to recognize all GAGE family
members; the number below each dot indicates the relative signal intensity. B. Relative quantification of GAGE proteins in nuclei and cytoplasm of
MZ2-MEL and SK-MEL-31 cells based on immunostaining intensities of confocal images measured using ImageJ64 software.
doi:10.1371/journal.pone.0045819.g008
GAGE Proteins Bind GCL
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75 mM NaCl, and a small fraction of complex 1 remained stable
at 250 mM NaCl (Fig. 7D).
We used the BindN nucleic acid prediction program [42] set to
a specificity of 95% to predict potential DNA binding residues in
GAGE12I. This program identified GAGE12I residues 4–17 as a
putative DNA binding domain (Fig. 7E), but this needs to be
verified experimentally.
The above results showed a GAGE concentration of at least
10 ng/ml (730 nM) was required to bind DNA at a concentra-
tion of 1 pg/ml (17 pM), corresponding to a molar ratio of 43:1
(GAGE12I:DNA). To determine if these GAGE concentrations
were physiologically relevant, we measured the GAGE content
in MZ2-MEL and SK-MEL-31 melanoma cell lysates against
known amounts of recombinant GAGE12I using dot blotting.
MZ2-MEL and SK-MEL-31 cells were found to contain
0.53 pg and 0.29 pg GAGE protein per cell, respectively
(Fig. 8A). Based on an estimated melanoma cell diameter of
,15 mm (assuming a spherical form), the concentrations were
conservatively calculated to be 299 ng/ml (23 mM) in MZ2-MEL
cells and 164 ng/ml (12 mM) in SK-MEL-31 cells. In both cell
lines, confocal microscopy suggested the GAGE signal was 2–3
times more intense in the nucleus than the cytoplasm (Fig. 8B).
We concluded that the nuclear concentration of GAGE proteins
in these cells is well above that (7.3 mM) required for ,50%
binding to DNA in vitro.
Discussion
Functional characterization of GAGE proteins is important to
understand their roles in cancer cell and germ cell biology and to
evaluate their therapeutic potential as cancer targets. This study
revealed that GAGE proteins interact directly or indirectly with
GCL, and that GCL recruits GAGE proteins to the nuclear
envelope in cells. We further demonstrated that GCL and GAGE
members co-express in human testis and cancer cells. GCL is
important for nuclear envelope integrity and germ cell develop-
ment in both Drosophila and mice [9,10]. GCL concentrates near
the nuclear inner membrane, possibly reflecting its direct binding
to LEM-domain proteins [12–14]. In Drosophila, GCL is required
to silence transcription in germ cells [11]. In mammalian cells,
GCL binds DP directly and reduces expression of E2F-DP-
activated genes [29]. These findings implicate GCL as a negative
regulator of DP activity. Our evidence suggests GCL also recruits
GAGE proteins to the nuclear envelope. Whether this recruitment
sequesters and depletes GAGE from other sites of action (as
proposed for certain transcription factors; [43]), or is required for
GAGE to function, or whether GCL is itself regulated by GAGE,
remain unknown.
We found that GAGE proteins are intrinsically-disordered
proteins that can bind dsDNA directly. Other intrinsically-
disordered dsDNA-binding proteins include High Mobility Group
(HMG) domain proteins and methyl-CpG binding Protein 2
(MeCP2) [44,45]. The cancer-germline antigen PAGE4, which is
both evolutionarily and structurally related to GAGE proteins
(32% identity to GAGE12I), is also intrinsically disordered and
exhibit DNA-binding properties [46]. Unstructured polypeptides
often adopt folded structures upon binding their biological targets
[41,47]. Both the DNA-binding region of GAGE, and the
structural basis of GAGE binding to DNA or chromatin, are
important topics for future investigation. Our current results
suggest GAGE proteins bind dsDNA in a sequence-independent
manner, similar to HMG domain proteins. However potential
preferential binding (e.g., to A/T-rich DNA sequences, as seen for
chromatin regulator SATB1; [25]) is not ruled out. Our gel-shift
experiments revealed detectable binding to 90-bp dsDNA
fragments (17 pM) at a GAGE12I concentration of 0.73 mM,
and approximately 50% binding at a GAGE12I concentration of
7.3 uM. These concentrations were well below the estimated
GAGE protein concentrations in nuclei of melanoma cells, and
suggested an in vitro binding stoichiometry of 43-to-1 (GAGE12I-
to-DNA) at 50% binding. Since GAGE proteins form stable
dimers and higher order oligomers [2], we hypothesize this high
molar ratio reflects concentration-dependent oligomerization of
GAGE proteins.
We do not yet understand the significance of GAGE binding to
DNA in vivo, or whether this is influenced by GCL. However we
speculate GAGE proteins might bridge chromatin to GCL-
associated protein complexes at the nuclear envelope and thereby
regulate chromatin organization and function [22,48]. In the
human germ cell lineage, GAGE proteins are present in
primordial germ cells (PGCs) and disappear just before the first
meiotic division [35,49]. PGCs proliferate and migrate from the
dorsal yolk sac via the dorsal mesentery to invade and colonize the
gonadal ridges [50]. This process involves a sequence of epigenetic
events that reorganize and reprogram chromatin, and ultimately
shift the cell from a somatic to a germ cell state [51]. These
epigenetic changes are still poorly characterized, but include
genome-wide loss of DNA methylation, gradual loss of H3K9me2
and global gain of H3K27me3 [52]. Notably, epigenetic changes
are also central to tumorigenesis, and phenotypic similarities
between germ cells and cancer cells suggest potential activation of
a gamete-related differentiation program in cancer cells [5]. We
therefore speculate that GAGE family members have novel roles
in higher-order chromatin reorganization and reprogramming in
germ cells and cancer cells.
Materials and Methods
Immunoassays
Antibodies used in this study were: Mouse anti-GAGE (M3 [4];
immunocytochemistry [ICC], 1/100 dilution; western blot [WB],
1/5000 dilution), rabbit anti-Myc (A14; Santa Cruz Biotech,
Heidelberg, Germany; ICC, 1/100), rabbit anti-GCL (Santa Cruz
Biotech; WB, 1/1000), rabbit anti-GCL (Sigma Aldrich, Brondby,
Denmark; WB, 1/1000), mouse anti-beta-Actin (Ab6276; Abcam,
Cambridge, UK; WB, 1/200.000); FITC-conjugated goat anti-
mouse IgG (Dako, Glostrup, Denmark; ICC, 1/400), Cy3-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories, West Grove, PA, USA; ICC, 1/400).
Western blots and cell staining were described previously [4].
For dot blots, we spotted recombinant GAGE12I or cellular lysates
(made in PBS using bead mill homogenization) onto activated
PVDF membrane; air-dried membranes were processed as
described for Western blots and quantified using a Fusion Fx7
imager (Vilber Lourmat Deutschland GmbH, Eberhardzell,
Deutschland).
Yeast Two-hybrid Screen
The yeast two-hybrid screen was done by ProteinLinks
(Pasadena, CA, USA). The GAGE12I (NM_001098418.1)
coding sequence was cloned into the bait vector pCWX200
for TetR-based screening, and screened by mating the bait
strain Y304 with library strain EGY42 (MATa). About 20
million independent human testes cDNA library clones (about
20 times library coverage) were screened on galactose-selective
medium lacking leucine, histidine, trytophan, and uracil. All
preliminary clones that grew in selective media were picked and
replicated onto four selective plates to assess URA3 (or LEU2)
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and LacZ reporters. To further validate interactions and
eliminate the possibility that spontaneous mutations caused
reporter gene activation, plasmids encoding each putative
partner were rescued and retransformed with GAGE12I
plasmid into EGY42. Clones that activated both reporters were
considered to encode GAGE12I interaction partners and
subsequently sequenced.
Luciferase Protein Interaction Assay
Gateway cloning (Invitrogen) was used to insert cDNAs
encoding GAGE2B and GAGE12I, full-length GCL or GCL
fragments into the pcDNA3-RLuc vector for fusion to Renilla
luciferase or the pTREX-Dest30-protA vector for Staphyloccus
Aureus protein A fusions. Proteins were transiently co-expressed
in HEK293 cells using 40 ng of expression construct and
0.05 ml Lipofectamine 2000 per well in 96 well plates. After 48
hours, cells were lysed in 20 mM Tris-HCl (pH 7.5), 250 mM
NaCl, 1% Triton X-100, 10 mM EDTA, 10 mM DTT,
including Protease Inhibitor Cocktail (Roche, Hvidovre, Den-
mark), Phosphatase Inhibitor Cocktail (Roche) and Benzonase
(Merck, Hellerup, Denmark). Lysates were incubated with anti-
rabbit IgG-coated magnetic beads (Invitrogen) (and a sample
saved to measure imput Luciferase activity) and the beads were
washed 6 times. Luciferase activity was measured in both lysates
and washed beads. As negative control Luciferase fusions were
co-transfected with Protein A dimers. Normalized signal-to-noise
ratios were calculated as (bound/input)/(bound negative con-
trol/input negative control). Z scores were then calculated from
the normalized data by subtracting the population mean of a
large set of independently-derived, non-interacting Lumier
protein pairs and dividing by the population standard deviation
(sample-population mean/population standard deviation).
Pull-down Assay
Recombinant N-terminally His-tagged GAGE12I, purified as
described [2], was bound to His-Trap Ni2+ beads and incubated
with recombinant GST-GCL (GMCL1) (Novus Biologicals,
Littleton, CO, USA) in 50 mM sodium phosphate pH 8.0,
200 mM NaCl, 0.01% Tween 20. After intensive washing proteins
were eluted by boiling in SDS-PAGE sample buffer and analyzed
by Western blotting.
Cell Culture and Transfections
Melanoma cell lines MZ2-MEL were a gift from Olivier De
Backer (Ludwig Institute for Cancer Research, Brussels, Belgium)
[53]. HeLa, HCT116, SK-MEL-31, HEK293 and A375 cells
were purchased from ATCC (Manassas, VA, USA). All cell lines
were maintained in Dulbecco’s modified Eagle’s medium (Invitro-
gen) supplemented with 10% fetal bovine serum (FBS), penicillin
(100 U/ml) and streptomycin (100 mg/ml). Serum starvation of
MZ2-MEL and SK-MEL-31 cells was done in DMEM, 0.5%
FBS, penicillin and streptomycin for 48 hours.
Transient DNA transfections were done using TransIT-LT1
transfection reagent (Mirus, Madison, WI, USA) per manufacturer
instructions. Constructs that express GAGE-1, GAGE-2B and
GAGE-12I with an N-terminal Flag-tag were described previously
[4]. The pCMV6-GCL vector, used to express GCL with a C-
terminal Myc-tag, was purchased from Origene (Rockville, MD,
USA).
Quantitative Analysis of GCL mRNA Expression
GCL and GAGE mRNA expression was quantified in 48
normal human tissues (Major human tissue qPCR panel; Origene)
and 93 cancers of different types (Cancer survey panel, Origene).
GCL expression was measured using a GCL Taqman expression
assay (Hs01587063_m1; Applied Biosystems, Carlsbad, CA, USA)
per manufacturer recommendations and GAGE expression was
measured using a previously established assay recognizing all
known GAGE members [35]. Expression levels were normalized
to endogenous beta-actin levels using primers: 59- CAA CTC
CAT CAT GAA GTG TGA C -39 and 59- GCC ATG CCA ATC
TCA TCT TG -39.
CD and NMR Spectroscopy
Far-UV CD measurements were performed on a Jasco J-810
spectropolarimeter. The protein concentration for all CD mea-
surements was kept constant (4.5 mM) in a buffer consisting of
100 mM NaCl and 50 mM sodium phosphate, pH 5.5. All spectra
were recorded at 298uK in a 1 mm Quarz Suprasil cuvette
(Hellma, Mu¨llheim, Germany). Four scans were accumulated. The
scanning speed was 50 nm/min and the intensity was measured
from 195 nm and 250 nm. All spectra were buffer corrected, and
the resulting spectra were smoothed using an FFT filter as supplied
by the Jasco software.
The NMR measurements were done at 298uK on a Varian
INOVA 800 MHz spectrometer equipped with a cryoprobe, in
aqueous buffer (100 mM NaCl, 50 mM sodium phosphate
pH 5.5, 0.15 mM DSS) with 10% D2O, at a protein concentration
of 4 mg/ml. A 1D 1H-NMR solvent presaturation experiment was
recorded using 256 transients at a sweep width of 12000 Hz. The
spectrum was referenced relative to DSS, processed and analyzed
using NMRPipe [54].
DNA Binding Assays
Recombinant GAGE12I or endogenous GAGE proteins
present in lysates from MZ2-MEL cells [4], were incubated with
either cellulose-immobilized native calf thymus DNA (GE
Healthcare, Hilleroed, Denmark) or cellulose alone in binding
buffer (20 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 mM DTT, 1%
BSA) for 12 hours at 4uC. Cellulose was washed 4 times in binding
buffer, and bound proteins were eluted by boiling in Tris-Glycine
SDS buffer, resolved by SDS-PAGE and western blotted for
GAGE as described above.
For electrophoretic mobility shift assays, 32P-labelled
dsDNA fragments (generated by restriction enzyme digest of
the pUC19 derivatives pT9CT9C and pT9C [55]) were
incubated with GAGE proteins in 10 ml binding buffer
(20 mM Tris pH 7.4, 50 mM NaCl, 1 mM DTT) for 5 min
or times indicated, at 20uC. Reactions were stopped by adding
3 ml loading buffer (50% glycerol, 100 ng/ml bromophenol
blue), and resolved immediately on 6% (55:1) polyacrylamide
gels (6–8 V/cm, 23uC, 90–120 minutes). GAGE-DNA com-
plexes were detected by autoradiography or using Phosphor-
imager storage screens.
Supporting Information
Figure S1 Protein structure predictions of GAGE1 and
GCL using the Jpred3 server (University of Dundee,
Scotland, UK).
(DOC)
Figure S2 Electrophoretic mobility shift assays of
GAGE12I binding to four sequence-unrelated dsDNA
fragments.
(DOC)
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